EP4180042A1 — A film coated tablet comprising micronized tofacitinib
Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2023-05-17 · 3y expired
What this patent protects
The present invention relates to a film coated tablet formulation comprising tofacitinib or pharmaceutically acceptable salts thereof wherein tofacitinib or pharmaceutically acceptable salts thereof has a d (0.5) particle size less than 20 µm. Further, the present invention also …
USPTO Abstract
The present invention relates to a film coated tablet formulation comprising tofacitinib or pharmaceutically acceptable salts thereof wherein tofacitinib or pharmaceutically acceptable salts thereof has a d (0.5) particle size less than 20 µm. Further, the present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.